UNLABELLED: Cardiac sympathetic denervation and ventricular arrhythmia are frequently observed in chronic Chagas cardiomyopathy (CCC). This study quantitatively evaluated the association between cardiac sympathetic denervation and sustained ventricular tachycardia (SVT) in patients with CCC. METHODS: We prospectively investigated patients with CCC and left ventricular ejection fraction (LVEF) greater than 35% with SVT (SVT group: n = 15; mean age ± SD, 61 ± 8 y; LVEF, 51% ± 8%) and patients without SVT (non-SVT group: n = 11; mean age ± SD, 55 ± 10 y; LVEF, 57% ± 10%). Patients underwent myocardial scintigraphy with (123)I-metaiodobenzylguanidine ((123)I-MIBG) for the evaluation of sympathetic innervation and resting perfusion with (99m)Tc-methoxyisobutylisonitrile ((99m)Tc-MIBI) for the evaluation of myocardial viability. A visual semiquantitative score was attributed for regional uptake of each radiotracer using a 17-segment left ventricular segmentation model (0, normal; 4, absence of uptake). A mismatch defect was defined as occurring in segments with a (99m)Tc-MIBI uptake score of 0 or 1 and a (123)I-MIBG score of 2 or more. RESULTS: Compared with the non-SVT group, the SVT group had a similar (99m)Tc-MIBI summed score (6.9 ± 7.5 vs. 4.4 ± 5.2, respectively, P = 0.69) but a higher (123)I-MIBG summed score (10.9 ± 7.8 vs. 22.4 ± 9.5, respectively, P = 0.007) and a higher number of mismatch defects per patient (2.0 ± 2.2 vs. 7.1 ± 2.0, respectively, P < 0.0001). The presence of more than 3 mismatch defects was strongly associated with the presence of SVT (93% sensitivity, 82% specificity; P = 0.0002). CONCLUSION: In CCC, the amount of sympathetically denervated viable myocardium is associated with the occurrence of SVT. Myocardial sympathetic denervation may participate in triggering malignant ventricular arrhythmia in CCC patients with relatively well-preserved ventricular function.
UNLABELLED: Cardiac sympathetic denervation and ventricular arrhythmia are frequently observed in chronic Chagas cardiomyopathy (CCC). This study quantitatively evaluated the association between cardiac sympathetic denervation and sustained ventricular tachycardia (SVT) in patients with CCC. METHODS: We prospectively investigated patients with CCC and left ventricular ejection fraction (LVEF) greater than 35% with SVT (SVT group: n = 15; mean age ± SD, 61 ± 8 y; LVEF, 51% ± 8%) and patients without SVT (non-SVT group: n = 11; mean age ± SD, 55 ± 10 y; LVEF, 57% ± 10%). Patients underwent myocardial scintigraphy with (123)I-metaiodobenzylguanidine ((123)I-MIBG) for the evaluation of sympathetic innervation and resting perfusion with (99m)Tc-methoxyisobutylisonitrile ((99m)Tc-MIBI) for the evaluation of myocardial viability. A visual semiquantitative score was attributed for regional uptake of each radiotracer using a 17-segment left ventricular segmentation model (0, normal; 4, absence of uptake). A mismatch defect was defined as occurring in segments with a (99m)Tc-MIBI uptake score of 0 or 1 and a (123)I-MIBG score of 2 or more. RESULTS: Compared with the non-SVT group, the SVT group had a similar (99m)Tc-MIBI summed score (6.9 ± 7.5 vs. 4.4 ± 5.2, respectively, P = 0.69) but a higher (123)I-MIBG summed score (10.9 ± 7.8 vs. 22.4 ± 9.5, respectively, P = 0.007) and a higher number of mismatch defects per patient (2.0 ± 2.2 vs. 7.1 ± 2.0, respectively, P < 0.0001). The presence of more than 3 mismatch defects was strongly associated with the presence of SVT (93% sensitivity, 82% specificity; P = 0.0002). CONCLUSION: In CCC, the amount of sympathetically denervated viable myocardium is associated with the occurrence of SVT. Myocardial sympathetic denervation may participate in triggering malignant ventricular arrhythmia in CCC patients with relatively well-preserved ventricular function.
Authors: Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne Journal: J Nucl Cardiol Date: 2016-06 Impact factor: 5.952
Authors: Ian P Clements; Ernest V Garcia; Ji Chen; Russell D Folks; Javed Butler; Arnold F Jacobson Journal: J Nucl Cardiol Date: 2015-03-19 Impact factor: 5.952
Authors: Leonardo Pippa Gadioli; Carlos Henrique Miranda; Antonio Osvaldo Pintya; Alexandre Baldini de Figueiredo; André Schmidt; Benedito Carlos Maciel; José Antonio Marin-Neto; Marcus Vinicius Simões Journal: J Nucl Cardiol Date: 2016-07-05 Impact factor: 5.952
Authors: Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman Journal: Annu Rev Pathol Date: 2018-10-24 Impact factor: 23.472
Authors: Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro Journal: Expert Rev Cardiovasc Ther Date: 2015-10-23
Authors: Antonia Pino-Marín; Germán José Medina-Rincón; Sebastian Gallo-Bernal; Alejandro Duran-Crane; Álvaro Ignacio Arango Duque; María Juliana Rodríguez; Ramón Medina-Mur; Frida T Manrique; Julian F Forero; Hector M Medina Journal: Pathogens Date: 2021-04-22